Puma Biotechnology Inc
NASDAQ:PBYI

Watchlist Manager
Puma Biotechnology Inc Logo
Puma Biotechnology Inc
NASDAQ:PBYI
Watchlist
Price: 3.235 USD -0.46% Market Closed
Market Cap: 160.6m USD

Intrinsic Value

The intrinsic value of one PBYI stock under the Base Case scenario is 5.514 USD. Compared to the current market price of 3.235 USD, Puma Biotechnology Inc is Undervalued by 41%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

PBYI Intrinsic Value
5.514 USD
Undervaluation 41%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Puma Biotechnology Inc

Valuation History Unavailable

Historical valuation for PBYI cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Puma Biotechnology Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Puma Biotechnology Inc

Current Assets 132.5m
Cash & Short-Term Investments 93.2m
Receivables 25.2m
Other Current Assets 14.2m
Non-Current Assets 63.7m
PP&E 4.2m
Intangibles 48.7m
Other Non-Current Assets 10.8m
Efficiency

Free Cash Flow Analysis
Puma Biotechnology Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Puma Biotechnology Inc

Revenue
232.7m USD
Cost of Revenue
-64.2m USD
Gross Profit
168.5m USD
Operating Expenses
-131.2m USD
Operating Income
37.2m USD
Other Expenses
818k USD
Net Income
38.1m USD
Fundamental Scores

PBYI Profitability Score
Profitability Due Diligence

Puma Biotechnology Inc's profitability score is 60/100. The higher the profitability score, the more profitable the company is.

60/100
Profitability
Score

Puma Biotechnology Inc's profitability score is 60/100. The higher the profitability score, the more profitable the company is.

PBYI Solvency Score
Solvency Due Diligence

Puma Biotechnology Inc's solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Long-Term Solvency
Short-Term Solvency
49/100
Solvency
Score

Puma Biotechnology Inc's solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PBYI Price Targets Summary
Puma Biotechnology Inc

Wall Street analysts forecast PBYI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PBYI is 5.61 USD with a low forecast of 4.04 USD and a high forecast of 7.35 USD.

Lowest
Price Target
4.04 USD
25% Upside
Average
Price Target
5.61 USD
73% Upside
Highest
Price Target
7.35 USD
127% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Puma Biotechnology Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for PBYI is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

PBYI Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one PBYI stock?

The intrinsic value of one PBYI stock under the Base Case scenario is 5.514 USD.

Is PBYI stock undervalued or overvalued?

Compared to the current market price of 3.235 USD, Puma Biotechnology Inc is Undervalued by 41%.

Back to Top